It has been agreed that Boehringer Ingelheim will be responsible for supplying Inspire with active drug substance pursuant to the terms of a separate commercial supply agreement.
This program will provide Inspire with the opportunity to build on our respiratory and allergy franchise, while leveraging our success in the market with the ocular form of epinastine, Elestat(R).
As an expert in the fields of ophthalmology and pharmacology, Gary has provided Inspire with
a wealth of knowledge," stated W.
Inspire's ophthalmology franchise currently includes Elestat(TM), which was approved by the FDA for the prevention of itching associated with allergic conjunctivitis, and is being co-promoted by Inspire with